Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Orally Active 7-Substituted (4-Benzyl-phthalazin-1-yl)-2-methyl-piperazin-1-yl]-nicotinonitriles as Active-site Inhibitors of Sphingosine-1-Phosphate Lyase for the Treatment of Multiple Sclerosis.
JC virus urinary excretion and seroprevalence in natalizumab-treated multiple sclerosis patients.
The radiologically isolated syndrome.
The intention to exercise and the execution of exercise among persons with multiple sclerosis - a qualitative metasynthesis.
Multiple sclerosis: Etiology, symptoms, incidence and prevalence, and implications for community living and employment.
Functional-structural correlations in the afferent visual pathway in pediatric demyelination.
Altered collagen expression in jugular veins in multiple sclerosis.
Multiple sclerosis: Phases of disease improvement unrelated to relapses.
Natalizumab treatment of progressive multiple sclerosis (NAPMS)
Regional but Not Global Brain Damage Contributes to Fatigue in Multiple Sclerosis.
The underdiagnosis of sleep disorders in patients with multiple sclerosis.
Common and Low Frequency Variants in MERTK Are Independently Associated with Multiple Sclerosis Susceptibility with Discordant Association Dependent upon HLA-DRB1*15:01 Status.
The Treatment of Lower Urinary Tract Symptoms in Patients With Multiple Sclerosis: A Systematic Review.
Disruption of oligodendrocyte gap junctions in experimental autoimmune encephalomyelitis.
Evaluating treatment effect within a multivariate stochastic ordering framework: Nonparametric combination methodology applied to a study on multiple sclerosis.
Interleukin-2 and the brain: dissecting central versus peripheral contributions using unique mouse models.
Transcriptional targeting of DCs with lentiviral vectors induces antigen-specific tolerance in a mouse model of multiple sclerosis.
CXCR7 suppression modulates microglial chemotaxis to ameliorate experimentally-induced autoimmune encephalomyelitis.
Mechanisms of action of ACTH in the management of relapsing forms of multiple sclerosis.
Novel immunoregulatory properties of EGCG on reducing inflammation in EAE.
Treatment of Neuropathic Pain and Functional Limitations Associated With Multiple Sclerosis Using an MRI-Compatible Spinal Cord Stimulator: A Case Report With Two Year Follow-Up and Literature Review.
Aggressive multiple sclerosis: proposed definition and treatment algorithm.
Mice devoid of tau have increased susceptibility to neuronal damage in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
Assessment of the reproducibility of oligoclonal IgM band detection for its application in daily clinical practice.
Cutting Edge: IL-6-Dependent Autoimmune Disease: Dendritic Cells as a Sufficient, but Transient, Source.
Pages
« first
‹ previous
…
244
245
246
247
248
249
250
251
252
…
next ›
last »